“Using PRP therapy to repair cartilage is still relatively experimental, but studies like this show it’s not only safe but also offers a significant improvement in function and quality of life for patients,” said Elizaveta Kon, MD, lead author for the study and Director of Nano-Biotecnology Laboratory at the Rizzoli Orthopaedic Institute in Bologna, Italy. “None of the patients treated experienced complications like infection, deep vein thrombosis or fever.”
During the study, 180 patients were treated for chronic pain or swelling of the knee with either PRP therapy or viscosupplementation, a more common hyaluronic acid-based treatment for cartilage damage. A total of 109 patients, with an average age of 56, reached a final evaluation. Both treatment groups demonstrated significant improvement based on higher post-treatment IKDC scores, which measure pain and basic function in follow-up interviews.
“As athletic participation has grown,” Kon noted, “new problems like cartilage lesions, or tears, continue to emerge. Finding the right approach to treatment is difficult, but PRP has emerged as a viable option according to our research.”
Kon also noted that long-term follow-ups for PRP treatments are needed to further evaluate the overall effectiveness of the therapy for future patients.
The American Orthopaedic Society for Sports Medicine (AOSSM) is a world leader in sports medicine education, research, communication and fellowship, and includes national and international orthopaedic sports medicine leaders. The Society works closely with many other sports medicine specialists, including athletic trainers, physical therapists, family physicians, and others to improve the identification, prevention, treatment, and rehabilitation of sports injuries. AOSSM is also a founding partner of the STOP Sports Injuries campaign to prevent overuse and traumatic injuries in kids. For more information on AOSSM or the STOP Sports Injuries campaign, visit www.sportsmed.org or www.stopsportsinjuries.org